RB Doubles R&D Spend In Search Of 'Game Changing’ OTC Innovation

With Reckitt's OTC sales falling 3% in 2020, the firm has committed to doubling its R&D spend in search of breakthrough product innovations.

Create New Products Concept - Modern Keyboard with Button. Selective Focus on the Create New Products Keypad. Hand Finger Press Create New Products Keypad. 3D Render.
• Source: Shutterstock

Reckitt Benckiser is doubling its spend on OTC drug research and development as it looks to turn around this ailing part of its Health business.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Innovation & IP

More from Health